Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary

Peila Chen1, Jamye F O'Neal, Nancy D Ebelt

  • 1Division of Pharmacology and Toxicology, Center for Molecular and Cellular Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, United States of America.

Plos One
|May 11, 2010
PubMed

Insights

JNK2 deficiency accelerates mammary tumor development and increases genomic instability in mice. JNK2 is crucial for DNA damage response and preventing replicative stress.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Oncogenes drive cell proliferation, leading to replicative stress, DNA damage, and genomic instability.
  • c-Jun N-terminal kinase (JNK) proteins are activated by cellular stress, but JNK isoform roles in tumor development are understudied.

Purpose of the Study:

  • To investigate the role of JNK2 in mammary tumor development and genomic stability.
  • To elucidate the mechanisms by which JNK2 influences DNA damage response and cell cycle progression.

Main Methods:

  • Utilized jnk2 knockout and wildtype mice expressing the Polyoma Middle T Antigen (PyV MT) transgene.
  • Assessed tumor development, multiplicity, aneuploidy, and DNA damage response markers (pH2AX, 53BP1 foci).
  • Performed comparative genomic hybridization (CGH) and in vitro cell-based assays (BrdU incorporation, protein expression analysis, RPA localization).

Main Results:

  • jnk2 knockout mice exhibited earlier mammary tumor onset and higher tumor multiplicity compared to wildtype controls.
  • Loss of JNK2 was associated with increased tumor aneuploidy, reduced DNA damage response, and heightened genomic instability.
  • In vitro studies showed jnk2 deficiency impaired response to replicative stress and DNA damage, affecting cell cycle regulators.

Conclusions:

  • JNK2 plays a critical role in preventing mammary tumor development and maintaining genomic stability.
  • JNK2 is essential for coordinating cell cycle progression and DNA damage repair mechanisms in response to stress.
  • JNK2 acts early in the DNA damage response pathway, facilitating the recruitment of repair proteins.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...